213 related articles for article (PubMed ID: 28782476)
1. A Case of Capecitabine-induced Hyperammonemia in a Patient with Colon Cancer.
Fang W; Fu Y; Wei J
Curr Drug Saf; 2018; 13(1):55-58. PubMed ID: 28782476
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Hyperammonemia Induced by Chemotherapy with 5-Fluorouracil for Metastatic Colon Cancer].
Tokuyama S; Fukunaga M; Konishi K; Honda S; Yukimoto R; Okamoto A; Saito A; Okada K; Ota H; Yokoyama S; Miki H; Kobayashi K
Gan To Kagaku Ryoho; 2018 Apr; 45(4):743-745. PubMed ID: 29650854
[TBL] [Abstract][Full Text] [Related]
3. [A case of 5-fluorouracil-induced hyperammmonia after chemotherapy for metastatic colon cancer].
Nakamura M; Kobashikawa K; Tamura J; Takaki R; Ohshiro M; Matayoshi R; Hirata T; Kinjyo F; Fujita J
Nihon Shokakibyo Gakkai Zasshi; 2009 Dec; 106(12):1744-50. PubMed ID: 19966516
[TBL] [Abstract][Full Text] [Related]
4. Hyperammonemia after capecitabine associated with occult impairment of the urea cycle.
Chu G; Salzman J
Cancer Med; 2019 May; 8(5):1996-2004. PubMed ID: 30977266
[TBL] [Abstract][Full Text] [Related]
5. Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible?
Di Federico A; Nuvola G; Sisi M; Lenzi B; Nobili E; Campana D
Anticancer Drugs; 2020 Nov; 31(10):1103-1105. PubMed ID: 32826413
[TBL] [Abstract][Full Text] [Related]
6. 5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.
Advani PP; Fakih MG
Anticancer Res; 2011 Jan; 31(1):335-8. PubMed ID: 21273620
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Colon Cancer with DPD Deficiency That Showed Severe Myelosuppression by CapeOX Adjuvant Chemotherapy after Colon Resection].
Watanabe H; Arita S; Takeuchi T; Oshima Y; Koike N
Gan To Kagaku Ryoho; 2018 Nov; 45(11):1661-1664. PubMed ID: 30449859
[TBL] [Abstract][Full Text] [Related]
8. Toxicity Associated with Capecitabine in Patients Suffering from Dihydropyrimidine Dehydrogenase Deficiency.
Bermejo-Pérez MJ; Galeote-Miguel AM; Rodelo-Haad LE; Alés-Díaz I; Durán-Ogalla G; Benavides-Orgaz M
Chemotherapy; 2014; 60(5-6):353-5. PubMed ID: 26330092
[TBL] [Abstract][Full Text] [Related]
9. [Four cases of 5-fluorouracil-related hyperammonemia in patients with large intestinal cancer and multiple liver metastases, including a case of hyperammonemia treated using hemodialysis].
Iida T; Wagatsuma K; Tani M; Sasaki H; Naganawa Y; Isshiki H; Murakami K; Satoh S; Shimizu H; Kaneto H
Nihon Shokakibyo Gakkai Zasshi; 2015 Feb; 112(2):287-96. PubMed ID: 25748155
[TBL] [Abstract][Full Text] [Related]
10. Drug Induced Lupus Erythematosus Due to Capecitabine and Bevacizumab Treatment Presenting with Prolonged Thrombocytopenia.
Ozaslan E; Eroglu E; Gok K; Senel S; Baldane S; Akyol L; Ozkan M
Rom J Intern Med; 2015; 53(3):282-5. PubMed ID: 26710505
[TBL] [Abstract][Full Text] [Related]
11. [A case of hyperammonemia with encephalopathy related to FOLFIRI chemotherapy for advanced colon cancer].
Toyokawa A; Nakajima T; Inui K; Yamashita H; Gon H; Kanemitsu K; Tanaka K; Tsukamoto T; Hamabe Y; Ishida T
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1167-9. PubMed ID: 19620810
[TBL] [Abstract][Full Text] [Related]
12. Secondary mania following cancer chemotherapy with capecitabine.
Garg H; Prakash S; Deb KS; Chadda RK
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29599381
[TBL] [Abstract][Full Text] [Related]
13. Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report.
Kigen G; Busakhala N; Njiru E; Chite F; Loehrer P
Pan Afr Med J; 2015; 21():228. PubMed ID: 26523170
[TBL] [Abstract][Full Text] [Related]
14. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
15. Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial.
Glen H; Cassidy J
Expert Rev Anticancer Ther; 2008 Apr; 8(4):547-51. PubMed ID: 18402521
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia.
Nishikawa Y; Funakoshi T; Horimatsu T; Miyamoto S; Matsubara T; Yanagita M; Nakagawa S; Yonezawa A; Matsubara K; Muto M
Cancer Chemother Pharmacol; 2017 Mar; 79(3):629-633. PubMed ID: 28204913
[TBL] [Abstract][Full Text] [Related]
17. Report of two cases of acute cardiac adverse events in patients with colorectal carcinoma receiving oral capecitabine.
Lampropoulos S; Roditis P; Koulouris E; Zafiris A; Tzimou M; Kyratlidis K; Pavlidis K; Godwin SA; Kosmas C
Anticancer Drugs; 2017 Aug; 28(7):801-807. PubMed ID: 28489615
[TBL] [Abstract][Full Text] [Related]
18. [Capecitabine-induced subacute cutaneous lupus: a case report].
Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
[TBL] [Abstract][Full Text] [Related]
19. [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].
Yamaguchi T; Fukuda M; Yasui H; Okazaki S; Kubo K; Tanaka M; Une Y; Setoguchi Y; Hanada K; Moriyama S; Tani M; Murakami T; Okuchi Y; Ogiso S; Hata H; Sakata S; Otani T; Yamato T; Ikai I
Gan To Kagaku Ryoho; 2012 Mar; 39(3):389-93. PubMed ID: 22421765
[TBL] [Abstract][Full Text] [Related]
20. Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses.
Ozaki Y; Imamaki H; Ikeda A; Oura M; Nakagawa S; Funakoshi T; Kataoka S; Nishikawa Y; Horimatsu T; Yonezawa A; Matsubara T; Yanagita M; Muto M; Watanabe N
Cancer Chemother Pharmacol; 2020 Nov; 86(5):693-699. PubMed ID: 33011861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]